Latest UCLA's Jonsson Comprehensive Cancer Center Stories
By Jane E. Brody To see Barry Cooper working out at the YMCA in Brooklyn, New York, every morning before going to work as a patent lawyer, you would be unlikely to guess that he has cancer.
UCLA researchers have developed a feedback control scheme that can search for the most effective drug combinations to treat a variety of conditions, including cancers and infections. The discovery could play a significant role in facilitating new clinical drug-cocktail trials.
Using nanotechnology, scientists from UCLA and Northwestern University have developed a localized and controlled drug delivery method that is invisible to the immune system, a discovery that could provide newer and more effective treatments for cancer and other diseases.
CLEVELAND, Oct. 2 /PRNewswire/ -- For the first time in a comic strip, Funky Winkerbean creator Tom Batiuk has depicted the death of a young wife and mother from the recurrence of breast cancer.
Genetically altered immune cells wiped out tumors in two men with a deadly form of skin cancer and kept the patients disease-free for at least 18 months, U.S. scientists said on Thursday.
LONDON (Reuters) - Many British patients suffering from cancer are waiting too long before being seen by a specialist, although referral times have improved over the last five years, a House of Commons committee said on Thursday.
Researchers have identified a gene mutation that may increase the risk of prostate cancer up to three times in African-American men with a family history of the disease.
The first clinical trial of a biologic nanoparticle designed to give back to cancer patients the tumor-busting gene they have lost is expected to start in September at Georgetown University Medical Center.
A product produced by lung cancer tumors fuels the cells that suppress immune function in patients and may be a target for Celebrex therapy, giving oncologists another weapon to fight cancer, according to a study by researchers at UCLA's Jonsson Cancer Center.